CZ9500200A3 - Polypeptide and use thereof - Google Patents

Polypeptide and use thereof

Info

Publication number
CZ9500200A3
CZ9500200A3 CZ95200A CZ20095A CZ9500200A3 CZ 9500200 A3 CZ9500200 A3 CZ 9500200A3 CZ 95200 A CZ95200 A CZ 95200A CZ 20095 A CZ20095 A CZ 20095A CZ 9500200 A3 CZ9500200 A3 CZ 9500200A3
Authority
CZ
Czechia
Prior art keywords
pct
sec
date
calcium channels
cells
Prior art date
Application number
CZ95200A
Other languages
English (en)
Other versions
CZ281539B6 (cs
Inventor
Douglas Phillips
Mary E Kelly
Nicholas A Saccomano
Robert A Volkmann
Original Assignee
Pfizer
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Nps Pharma Inc filed Critical Pfizer
Publication of CZ9500200A3 publication Critical patent/CZ9500200A3/cs
Publication of CZ281539B6 publication Critical patent/CZ281539B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
CZ95200A 1992-07-27 1993-06-10 Polypeptid a jeho použití CZ281539B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91953892A 1992-07-27 1992-07-27

Publications (2)

Publication Number Publication Date
CZ9500200A3 true CZ9500200A3 (en) 1995-10-18
CZ281539B6 CZ281539B6 (cs) 1996-10-16

Family

ID=25442279

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ95200A CZ281539B6 (cs) 1992-07-27 1993-06-10 Polypeptid a jeho použití

Country Status (28)

Country Link
US (1) US5599559A (cs)
EP (1) EP0656905B1 (cs)
JP (1) JP2571197B2 (cs)
KR (1) KR950702577A (cs)
CN (1) CN1086824A (cs)
AT (1) ATE157672T1 (cs)
AU (1) AU662066B2 (cs)
BR (1) BR9306796A (cs)
CA (1) CA2139947C (cs)
CZ (1) CZ281539B6 (cs)
DE (1) DE69313650T2 (cs)
DK (1) DK0656905T3 (cs)
ES (1) ES2105284T3 (cs)
FI (1) FI933349A7 (cs)
GR (1) GR3024637T3 (cs)
HR (1) HRP931050B1 (cs)
HU (1) HU213353B (cs)
IL (1) IL106424A0 (cs)
MX (1) MX9304497A (cs)
MY (1) MY131356A (cs)
NZ (1) NZ253611A (cs)
PL (1) PL307258A1 (cs)
RU (1) RU2104286C1 (cs)
SK (1) SK10395A3 (cs)
TW (1) TW271442B (cs)
WO (1) WO1994002511A1 (cs)
YU (1) YU51593A (cs)
ZA (1) ZA935370B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876958A (en) * 1988-04-04 1999-03-02 Sibia Neurosciences, Inc. Assays of cells expressing human calcium channels containing α1 β subunits
US5846757A (en) * 1988-04-04 1998-12-08 Sibia Neurosciences, Inc. Human calcium channel α1, α2, and β subunits and assays using them
US5874236A (en) * 1988-04-04 1999-02-23 Sibia Neurosciences. Inc. DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits
US6653097B1 (en) 1991-08-15 2003-11-25 Merck & Co., Inc. Human calcium channel compositions and methods
US5407820A (en) * 1988-04-04 1995-04-18 The Salk Institute Biotechnology/Industrial Associates, Inc. Calcium channel α-2 subunit DNAs and cells expressing them
US20040018510A1 (en) 1990-11-08 2004-01-29 Merck & Co., Inc. Human calcium channel compositions and methods
ATE139542T1 (de) 1988-04-04 1996-07-15 Salk Inst Biotech Ind Calciumkanal-zusammensetzungen und verfahren
US6387696B1 (en) 1988-04-04 2002-05-14 Merck & Co., Inc. Human calcium channel compositions and methods
US6096514A (en) * 1988-04-04 2000-08-01 Sibia Neurosciences, Inc. Human calcium channel compositions and methods
US6090623A (en) * 1993-08-11 2000-07-18 Merck & Co., Inc. Recombinant human calcium channel β4 subunits
ES2075796B1 (es) * 1993-08-17 1996-03-01 Pfizer Polipeptido de la agelenopsis aperta bloqueante de los canales de ca lcio
JP4086315B2 (ja) 1995-09-29 2008-05-14 ユニベルシタ デグリ スチュディ ディ シエナ 調節遺伝子およびその使用
DK1749836T3 (da) 1996-08-23 2009-08-31 Vegenics Ltd Rekombinant vaskulær endothelcellevækstfaktor D
US6528630B1 (en) 1997-12-03 2003-03-04 Merck & Co., Inc. Calcium channel compositions and methods
SI1096932T1 (sl) * 1998-07-10 2008-04-30 Novartis Pharma Ag Antihipertenzivna kombinacija valsartana in zaviralca kalcijevih kanalov
US8299211B2 (en) * 2005-09-30 2012-10-30 The Board Of Trustees Of The University Of Illinois Peptides and regulation of calcium channels
CN103768469A (zh) * 2012-10-23 2014-05-07 葛继云 一种治疗妇科炎症的中药组合物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731439A (en) * 1985-11-22 1988-03-15 Oncogen Snake venom growth arresting peptide
US4925664A (en) * 1986-10-20 1990-05-15 University Of Utah Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function
US5064657A (en) * 1986-10-20 1991-11-12 University Of Utah Spider toxins and methods for their use as blockers of amino acid receptor function
US5196204A (en) * 1986-10-20 1993-03-23 University Of Utah Research Foundation Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function
FI896136A7 (fi) * 1988-12-23 1990-06-24 Merrell Dow Pharma Hämähäkin Hololena curta myrkystä eristettyjä polypeptidejä
US5122596A (en) * 1989-09-29 1992-06-16 Pfizer Inc. Polypeptides useful as blockers of calcium channels

Also Published As

Publication number Publication date
SK10395A3 (en) 1995-06-07
CN1086824A (zh) 1994-05-18
DE69313650T2 (de) 1998-01-08
JPH07504685A (ja) 1995-05-25
RU2104286C1 (ru) 1998-02-10
TW271442B (cs) 1996-03-01
HRP931050B1 (en) 1999-04-30
FI933349L (fi) 1994-01-28
HUT67467A (en) 1995-04-28
WO1994002511A1 (en) 1994-02-03
YU51593A (sh) 1997-01-08
HU213353B (en) 1997-05-28
MX9304497A (es) 1994-04-29
FI933349A7 (fi) 1994-01-28
AU4407893A (en) 1994-02-14
HRP931050A2 (en) 1996-12-31
GR3024637T3 (en) 1997-12-31
MY131356A (en) 2007-08-30
CA2139947C (en) 1998-06-30
JP2571197B2 (ja) 1997-01-16
DE69313650D1 (en) 1997-10-09
KR950702577A (ko) 1995-07-29
ATE157672T1 (de) 1997-09-15
CA2139947A1 (en) 1994-02-03
EP0656905B1 (en) 1997-09-03
IL106424A0 (en) 1993-11-15
ZA935370B (en) 1995-01-26
EP0656905A1 (en) 1995-06-14
NZ253611A (en) 1996-09-25
RU95105340A (ru) 1996-10-27
CZ281539B6 (cs) 1996-10-16
US5599559A (en) 1997-02-04
HU9302158D0 (en) 1993-11-29
FI933349A0 (fi) 1993-07-26
BR9306796A (pt) 1998-12-08
ES2105284T3 (es) 1997-10-16
PL307258A1 (en) 1995-05-15
AU662066B2 (en) 1995-08-17
DK0656905T3 (da) 1997-10-20

Similar Documents

Publication Publication Date Title
TW271442B (cs)
EG20275A (en) Calcium channel blacking polypeptides from filistato hibernalis
CZ112695A3 (en) Polypeptide and use thereof
CA2146367A1 (en) Calcium channel blocking polypeptides from heteropoda venatoria
NO950293L (no) Kalsiumkanalblokkerende polypeptid fra Agelenopsis aperta
ES2075796A1 (es) Polipeptido de la agelenopsis aperta bloqueante de los canales de ca lcio